KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Goodwill (2016 - 2025)

Historic Goodwill for Novavax (NVAX) over the last 17 years, with Q3 2025 value amounting to $113.1 million.

  • Novavax's Goodwill fell 1079.63% to $113.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.1 million, marking a year-over-year decrease of 1079.63%. This contributed to the annual value of $107.5 million for FY2024, which is 1567.31% down from last year.
  • Novavax's Goodwill amounted to $113.1 million in Q3 2025, which was down 1079.63% from $113.0 million recorded in Q2 2025.
  • Novavax's 5-year Goodwill high stood at $134.3 million for Q2 2021, and its period low was $107.5 million during Q4 2024.
  • In the last 5 years, Novavax's Goodwill had a median value of $126.3 million in 2022 and averaged $123.9 million.
  • Its Goodwill has fluctuated over the past 5 years, first skyrocketed by 16182.08% in 2021, then plummeted by 1567.31% in 2024.
  • Quarter analysis of 5 years shows Novavax's Goodwill stood at $131.5 million in 2021, then decreased by 3.92% to $126.3 million in 2022, then increased by 0.89% to $127.5 million in 2023, then dropped by 15.67% to $107.5 million in 2024, then rose by 5.21% to $113.1 million in 2025.
  • Its last three reported values are $113.1 million in Q3 2025, $113.0 million for Q2 2025, and $112.0 million during Q1 2025.